USP22 and non-small cell lung carcinoma: To investigate the relevance of our in vitro findings to NSCLC tumorigenesis in vivo, we monitored the growth of tumors derived from A549 cells transfected with USP22 shRNA or SCR shRNA in a xenograft mouse model.